|
|
|
(State or other jurisdiction of
incorporation)
|
(Commission File Number)
|
(I.R.S. Employer
Identification No.)
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencements communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange
on which registered
|
|
|
|
|
|
Exhibit No.
|
|
Description
|
|
Fourth Promissory Note, dated as of February 8, 2024 and issued to ARYA Sciences Holdings IV.
|
|
104
|
|
Cover Page Interactive Data File (embedded within the Inline XBRL document).
|
|
ARYA Sciences Acquisition Corp IV
|
Date: February 9, 2024
|
By:
|
/s/ Michael Altman
|
|
|
|
Name: Michael Altman
|
|
|
|
Title: Chief Financial Officer
|
|